iX Biopharma (42C.SI SES) -5.43% pre-mkt 03 Feb 2026: earnings may reset targets
Pre-market trading on 03 Feb 2026 shows iX Biopharma Ltd. (42C.SI stock) down 5.43% to S$0.174 as investors prepare for an earnings release on 06 Feb 2026. The move comes on volume of 8,911,100 shares and follows a recent rally that lifted the stock 48.72% over three months. Today’s drop tightens focus on margins, R&D spend and clinical-readout timing ahead of the SES-listed biotech’s report.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
